Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04297384 · ClinicalTrials.gov registry record · NA

Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice

A NA study, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
NA
Development phase
174
Enrollment target

NCT04297384 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 174 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04297384, a NA study, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
NA
Development phase
174 participants
Enrollment target

Study Summary

This trial studies the impact of the breast cancer pathways program on the patient experience, including decision making and quality of life. Measuring how the breast cancer pathways program affects decision making and quality of life in patients may help doctors improve cancer education.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Survey Administration
  • OTHER Informational Intervention

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2019-02-06
Est. Completion 2022-08-30
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT04297384

The ClinicalTrials.gov registry entry for NCT04297384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04297384 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04297384 about?

NCT04297384 is a clinical study titled "Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice". This trial studies the impact of the breast cancer pathways program on the patient experience, including decision making and quality of life. Measuring how the breast cancer pathways program affects decision making and quality of life in patients may help doctors improve cancer education.

What is the current status of trial NCT04297384?

This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2019-02-06. Estimated completion is 2022-08-30.

What interventions are being tested in trial NCT04297384?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT04297384?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.